Corrigendum: Interleukin-2-Inducible T-Cell Kinase Deficiency—New Patients, New Insight?

Corrigendum: Interleukin-2-Inducible T-Cell Kinase Deficiency—New Patients, New Insight?

Bibliographic Details
Main Authors: Sujal Ghosh, Ingo Drexler, Sanil Bhatia, Heiko Adler, Andrew R. Gennery, Arndt Borkhardt
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-10-01
Series:Frontiers in Immunology
Subjects:
Epstein–Barr virus-related malignancies
combined immunodeficiency
Interleukin-2-inducible T-cell kinase
lymphoproliferative disorders
primary immunodeficiency
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2018.02197/full
id doaj-a1102431c922459cbf2883fb6b1ee772
record_format Article
spelling doaj-a1102431c922459cbf2883fb6b1ee7722020-11-25T00:33:29ZengFrontiers Media S.A.Frontiers in Immunology1664-32242018-10-01910.3389/fimmu.2018.02197419299Corrigendum: Interleukin-2-Inducible T-Cell Kinase Deficiency—New Patients, New Insight?Sujal Ghosh0Ingo Drexler1Sanil Bhatia2Heiko Adler3Heiko Adler4Heiko Adler5Andrew R. Gennery6Arndt Borkhardt7Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Center of Child and Adolescent Health, Heinrich-Heine-University, Düsseldorf, GermanyInstitute for Virology, Medical Faculty, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, GermanyDepartment of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Center of Child and Adolescent Health, Heinrich-Heine-University, Düsseldorf, GermanyResearch Unit Lung Repair and Regeneration, Comprehensive Pneumology Center, Helmholtz Zentrum München—Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Munich, GermanyUniversity Hospital Grosshadern, Ludwig-Maximilians-Universität München, Munich, GermanyGerman Center for Lung Research (DZL), Giessen, GermanyPaediatric Immunology and HSCT, Newcastle University and Great North Children's Hospital, Newcastle upon Tyne, United KingdomDepartment of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Center of Child and Adolescent Health, Heinrich-Heine-University, Düsseldorf, Germanyhttps://www.frontiersin.org/article/10.3389/fimmu.2018.02197/fullEpstein–Barr virus-related malignanciescombined immunodeficiencyInterleukin-2-inducible T-cell kinaselymphoproliferative disordersprimary immunodeficiency
collection DOAJ
language English
format Article
sources DOAJ
author Sujal Ghosh
Ingo Drexler
Sanil Bhatia
Heiko Adler
Heiko Adler
Heiko Adler
Andrew R. Gennery
Arndt Borkhardt
spellingShingle Sujal Ghosh
Ingo Drexler
Sanil Bhatia
Heiko Adler
Heiko Adler
Heiko Adler
Andrew R. Gennery
Arndt Borkhardt
Corrigendum: Interleukin-2-Inducible T-Cell Kinase Deficiency—New Patients, New Insight?
Frontiers in Immunology
Epstein–Barr virus-related malignancies
combined immunodeficiency
Interleukin-2-inducible T-cell kinase
lymphoproliferative disorders
primary immunodeficiency
author_facet Sujal Ghosh
Ingo Drexler
Sanil Bhatia
Heiko Adler
Heiko Adler
Heiko Adler
Andrew R. Gennery
Arndt Borkhardt
author_sort Sujal Ghosh
title Corrigendum: Interleukin-2-Inducible T-Cell Kinase Deficiency—New Patients, New Insight?
title_short Corrigendum: Interleukin-2-Inducible T-Cell Kinase Deficiency—New Patients, New Insight?
title_full Corrigendum: Interleukin-2-Inducible T-Cell Kinase Deficiency—New Patients, New Insight?
title_fullStr Corrigendum: Interleukin-2-Inducible T-Cell Kinase Deficiency—New Patients, New Insight?
title_full_unstemmed Corrigendum: Interleukin-2-Inducible T-Cell Kinase Deficiency—New Patients, New Insight?
title_sort corrigendum: interleukin-2-inducible t-cell kinase deficiency—new patients, new insight?
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2018-10-01
topic Epstein–Barr virus-related malignancies
combined immunodeficiency
Interleukin-2-inducible T-cell kinase
lymphoproliferative disorders
primary immunodeficiency
url https://www.frontiersin.org/article/10.3389/fimmu.2018.02197/full
work_keys_str_mv AT sujalghosh corrigenduminterleukin2inducibletcellkinasedeficiencynewpatientsnewinsight
AT ingodrexler corrigenduminterleukin2inducibletcellkinasedeficiencynewpatientsnewinsight
AT sanilbhatia corrigenduminterleukin2inducibletcellkinasedeficiencynewpatientsnewinsight
AT heikoadler corrigenduminterleukin2inducibletcellkinasedeficiencynewpatientsnewinsight
AT heikoadler corrigenduminterleukin2inducibletcellkinasedeficiencynewpatientsnewinsight
AT heikoadler corrigenduminterleukin2inducibletcellkinasedeficiencynewpatientsnewinsight
AT andrewrgennery corrigenduminterleukin2inducibletcellkinasedeficiencynewpatientsnewinsight
AT arndtborkhardt corrigenduminterleukin2inducibletcellkinasedeficiencynewpatientsnewinsight
_version_ 1725316433004462080

Similar Items